Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
ALKS
ALKS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ALKS News
Alkermes Acquires Avadel to Expand Product Portfolio
3d ago
Newsfilter
Goldman Sachs Downgrades Super Micro Computer to Sell with $26 Price Target
Jan 20 2026
Benzinga
ImmunityBio (IBRX) Shares Surge 39.8% on Positive QUILT-106 Study Data
Jan 19 2026
NASDAQ.COM
Alkermes Receives FDA Breakthrough Therapy Designation for Alixorexton, Potentially Accelerating Development
Jan 19 2026
Yahoo Finance
Super Micro Computer Rated Sell, Medline Rated Buy by Analysts
Jan 17 2026
CNBC
Guess, NESR, and Alkermes Rated Buy with Strong Value Characteristics
Jan 14 2026
NASDAQ.COM
Avadel Pharmaceuticals Shareholders Approve Alkermes Buyout
Jan 12 2026
Yahoo Finance
Alkermes Receives FDA Breakthrough Therapy Designation for Alixorexton in Treating Narcolepsy Type 1
Jan 06 2026
NASDAQ.COM
Alkermes Receives FDA Breakthrough Therapy Designation for Alixorexton in Treating Narcolepsy Type 1
Jan 06 2026
Newsfilter
Avadel Pharmaceuticals to be Sold to Alkermes for $18.50 per Share
Dec 12 2025
PRnewswire
Alkermes to Acquire Avadel Pharmaceuticals; Proposal Details Released
Dec 05 2025
Globenewswire
Alkermes to Acquire Avadel; Proposal Details Released
Dec 05 2025
Newsfilter
Alkermes to Acquire Avadel; Shareholder Vote Scheduled for January 2026
Dec 03 2025
Globenewswire
Alkermes to Acquire Avadel; Shareholder Vote Scheduled for January 2026
Dec 03 2025
Newsfilter
Alkermes to Acquire Avadel; Shareholder Vote Scheduled for January 12, 2026
Dec 01 2025
Newsfilter
Insmed Shares Climb Following EU Approval of Lung Disease Treatment, Brinsupri
Nov 19 2025
NASDAQ.COM
Show More News
